Credit Capital Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-750
Closed -$292K 48
2025
Q2
$292K Buy
+750
New +$302K 0.41% 26
2023
Q2
Sell
-1,022
Closed -$470K 62
2023
Q1
$470K Buy
+1,022
New +$486K 0.61% 34

Other funds holding ELV

Credit Capital Investments's ELV Position: Q3 2025 in Review

Credit Capital Investments sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 750 shares — an estimated $292K sold.

Credit Capital Investments first reported a position in ELV in Q1 2023 and held it in 2 quarters. The position peaked at $470K in Q1 2023. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Credit Capital Investments reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Credit Capital Investments sold 750 Elevance Health shares in Q3 2025, an estimated $292K.
  • Credit Capital Investments first reported a position in Elevance Health in Q1 2023 and held it in 2 quarters.
  • Credit Capital Investments's Elevance Health position peaked at $470K in Q1 2023.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Credit Capital Investments's 13F filing for Q3 2025, filed 14 Nov 2025.